- Home
- ENGN vs NAUT Comparison
ENGN vs NAUT Comparison
Compare ENGN & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENGN | NAUT |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | Canada | United States |
| Employees | 82 | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 647.1M | 383.5M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ENGN | NAUT |
|---|---|---|
| Price | $6.19 | $3.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $21.00 | $4.00 |
| AVG Volume (30 Days) | ★ 540.8K | 342.1K |
| Earning Date | 03-09-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.66 | $0.62 |
| 52 Week High | $12.25 | $4.31 |
Technical Indicators
Market Signals| Indicator | ENGN | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 27.87 | 59.59 |
| Support Level | $6.03 | $1.93 |
| Resistance Level | $8.14 | N/A |
| Average True Range (ATR) | 0.56 | 0.35 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 9.36 | 53.33 |
Price Performance
Historical ComparisonAbout ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.